Sign in to continue:

Friday, July 31st, 2026

Day: May 15, 2026

us corporate news

Koil Energy Solutions, Inc. (KLNG) Q1 2026 10-Q Report: Financial Statements, Risk Factors, and Lease Disclosures

Minichart
May 15, 2026

Koil Energy Solutions, Inc. Q1 2026 Financial Report: Key Hi...

Continue Reading 0
us corporate news

Sensei Biotherapeutics, Inc. Q1 2026 10-Q Filing: Financial Statements, Risk Factors, and Management Analysis

Minichart
May 15, 2026

Sensei Biotherapeutics, Inc. Q1 2026 Financial Report - Inve...

Continue Reading 0
us corporate news

Galectin Therapeutics Q1 2026 Financial Report: Earnings, Balance Sheet, and Key Disclosures

Minichart
May 15, 2026

Detailed Financial Report: Galectin Therapeutics Inc. Q1 202...

Continue Reading 0
us corporate news

Immuneering Corp Q1 2026 10-Q Report: Financial Results, Risk Factors, and Forward-Looking Statements

Minichart
May 15, 2026

Immuneering Corporation Q1 2026 Financial Report: Key Takeaw...

Continue Reading 0
us corporate news

Local Bounti Corporation 2026 Q1 10-Q: Financial Performance, Risks, and Forward-Looking Statements

Minichart
May 15, 2026

Local Bounti Q1 2026 Financial Report: Key Highlights and In...

Continue Reading 0
us corporate news

Tancheng Group Co., Ltd. 2026 Q1 10-Q Report: Financial Results, Business Overview, and Risk Disclosures

Minichart
May 15, 2026

Tancheng Group Co., Ltd. Q1 2026 Financial Report: Key Detai...

Continue Reading 0
us corporate news

Rein Therapeutics, Inc. Q1 2026 10-Q Report: Financial Statements, Risk Factors, and Forward-Looking Statements

Minichart
May 15, 2026

Rein Therapeutics, Inc. Q1 2026 Financial Report: Key Highli...

Continue Reading 0
us corporate news

Creative Realities, Inc. (CREX) Q1 2026 Financial Results and SEC Filing Overview

Minichart
May 15, 2026

Creative Realities, Inc. Q1 2026 Financial Results – Investo...

Continue Reading 0
us corporate news

GT Biopharma, Inc. Q1 2026 Financial Results: Quarterly Report, Financial Statements, and Key Disclosures

Minichart
May 15, 2026

GT Biopharma, Inc. Q1 2026 Financial Report: Key Highlights ...

Continue Reading 0
us corporate news

Our Bond Inc. Q1 2026 Financial Results: Comprehensive Loss, Nasdaq Listing, Direct Listing Costs, and Equity Changes 51 53 54 57 58 69 75

Minichart
May 15, 2026

Our Bond Inc. Q1 2026 Financial Results – Detailed Investor ...

Continue Reading 0